FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies

FDA, USDA, EPA announce the signing of a formal agreement to renew their Federal interagency Collaboration to Reduce Food Loss and Waste (FIFLAW) and welcome USAID making a significant expansion of the federal collaboration.

Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests.

The FDA is creating a new advisory committee related to potential treatments for genetic metabolic diseases. Genetic metabolic diseases are conditions that disrupt an individual's metabolism, which is the chemical process responsible for converting food into energy and eliminating toxins from the bo